2022 annual financial data
TransCode Therapeutics 2022 Operating margin
TransCode Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -18,665,814 USD and net income was -17,564,968 USD.
Operating cash flow was -15,762,512 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,665,814 USD
- Net income
- -17,564,968 USD
- Operating cash flow
- -15,762,512 USD